Researchers examined 19,978 UC patients and 13,005 Crohn’s disease patients.
• 80 percent of UC and Crohn’s disease patients had one or more suboptimal therapy marker
• Total costs per Crohn’s disease patient were significantly higher ($18,736) with suboptimal therapy markers compared to patients without suboptimal markers ($10,878)
• Total costs per UC patient with suboptimal therapy markers was $12,679 compared to $9,653 in UC patients without suboptimal markers
More Articles on Gastroenterology:
GI in the News: 6 Gastroenterologist Moves & Honors
5 Things to Know About Removing Barriers to Colorectal Cancer Screening Act
Radiofrequency Therapy for GERD: DDW Panel Snapshot
